Atlas Trials

Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

Clinical trial NCT01844947 · COMPLETED

Trial details

NCT number
NCT01844947
Sponsor
Dr Anders Ullén
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Urothelial CarcinomaBladder CancerRenal Pelvis CancerUreter CancerUrethra Cancer
Start date
2012-05-01
Primary completion
2017-10-18
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.